keyword
https://read.qxmd.com/read/38616285/carnitine-palmitoyltransferase-ii-cpt-ii-deficiency-responsible-for-refractory-cardiac-arrhythmias-acute-multiorgan-failure-and-early-fatal-outcome
#1
JOURNAL ARTICLE
Gregorio Serra, Vincenzo Antona, Vincenzo Insinga, Giusy Morgante, Alessia Vassallo, Simona La Placa, Ettore Piro, Sergio Salerno, Ingrid Anne Mandy Schierz, Eloisa Gitto, Mario Giuffrè, Giovanni Corsello
BACKGROUND: Carnitine palmitoyltransferase II (CPT II) deficiency is a rare inborn error of mitochondrial fatty acid metabolism with autosomal recessive pattern of inheritance. Its phenotype is highly variable (neonatal, infantile, and adult onset) on the base of mutations of the CPT II gene. In affected subjects, long-chain acylcarnitines cannot be subdivided into carnitine and acyl-CoA, leading to their toxic accumulation in different organs. Neonatal form is the most severe, and all the reported patients died within a few days to 6 months after birth...
April 14, 2024: Italian Journal of Pediatrics
https://read.qxmd.com/read/38615785/effects-of-ddt-and-dde-on-placental-cholinergic-receptors
#2
JOURNAL ARTICLE
Recep Uyar, Yağmur Turgut, H Tolga Çelik, M Altay Ünal, Özgür Kuzukıran, Özgür Özyüncü, Ahmet Ceylan, Özge Özgenç Çinar, Ümmü Gülsüm Boztepe, Hilal Özdağ, Ayhan Filazi, Begüm Yurdakök-Dikmen
The placental cholinergic system; known as an important factor in intracellular metabolic activities, regulation of placental vascular tone, placental development, and neurotransmission; can be affected by persistent organic pesticides, particularly organochlorine pesticides(OCPs), which can influence various epigenetic regulations and molecular pathways. Although OCPs are legally prohibited, trace amounts of the persistent dichlorodiphenyltrichloroethane(DDT) are still found in the environment, making prenatal exposure inevitable...
April 12, 2024: Reproductive Toxicology
https://read.qxmd.com/read/38613152/fetal-cardiac-screening-1st-trimester-and-beyond
#3
REVIEW
Lindsay R Freud, Lynn L Simpson
Congenital heart defects (CHD) are the most common birth defect and a leading cause of infant morbidity and mortality. CHD often occurs in low-risk pregnant patients, which underscores the importance of routine fetal cardiac screening at the time of the 2nd trimester ultrasound. Prenatal diagnosis of CHD is important for counseling and decision-making, focused diagnostic testing, and optimal perinatal and delivery management. As a result, prenatal diagnosis has led to improved neonatal and infant outcomes. Updated fetal cardiac screening guidelines, coupled with technological advancements and educational efforts, have resulted in increased prenatal detection of CHD in both low- and high-risk populations...
April 12, 2024: Prenatal Diagnosis
https://read.qxmd.com/read/38611642/value-of-non-coding-rna-expression-in-biofluids-to-identify-patients-at-low-risk-of-pathologies-associated-with-pregnancy
#4
REVIEW
Anne-Gael Cordier, Elie Zerbib, Amélia Favier, Yohann Dabi, Emile Daraï
Pregnancy-related complications (PRC) impact maternal and fetal morbidity and mortality and place a huge burden on healthcare systems. Thus, effective diagnostic screening strategies are crucial. Currently, national and international guidelines define patients at low risk of PRC exclusively based on their history, thus excluding the possibility of identifying patients with de novo risk (patients without a history of disease), which represents most women. In this setting, previous studies have underlined the potential contribution of non-coding RNAs (ncRNAs) to detect patients at risk of PRC...
March 29, 2024: Diagnostics
https://read.qxmd.com/read/38610747/navigating-uncertain-waters-first-trimester-screening-s-role-in-identifying-neonatal-complications
#5
JOURNAL ARTICLE
Grzegorz Swiercz, Anna Zmelonek-Znamirowska, Karol Szwabowicz, Justyna Armanska, Karolina Detka, Marta Mlodawska, Jakub Mlodawski
Background : Contemporary diagnostic methods aimed at assessing neonatal outcomes predominantly rely on the medical history of pregnant women. Ideally, universal biomarkers indicating an increased risk of delivering infants in poor clinical condition, with a heightened likelihood of requiring hospitalization in a Neonatal Intensive Care Unit (NICU), would be beneficial for appropriately stratifying pregnant women into a high-risk category. Our study evaluated whether biochemical and ultrasonographical markers universally used in first-trimester screenings for non-heritable chromosomal aberrations could serve this purpose...
March 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38610065/parental-questions-about-sex-chromosome-aneuploidies-regarding-sex-gender-and-sexual-orientation-as-reported-by-genetic-counselors-in-a-prenatal-setting
#6
JOURNAL ARTICLE
Sarah Burzynski, Jaqueline Leonard, Jenna Plamondon Albrecht, Lauren E Doyle, Rachel Mills
The introduction of cell-free DNA screening has resulted in increased prenatal identification of sex chromosome aneuploidies (SCAs). This study aimed to evaluate genetic counselor experiences disclosing SCAs positive prenatal screening or testing results and genetic counselor-reported parental questions regarding sex, gender, and sexual orientation. Forty-eight prenatal genetic counselors completed the survey. When asked to quantify their experiences, 97.9% of counselors reported disclosing a SCAs positive screen result within the previous year, and 81...
April 12, 2024: Journal of Genetic Counseling
https://read.qxmd.com/read/38608208/comprehensive-recommendations-for-the-clinical-management-of-pregnant-women-with-noninvasive-prenatal-test-results-suspicious-of-a-maternal-malignancy
#7
JOURNAL ARTICLE
Catharina J Heesterbeek, Liesbeth Lenaerts, Vivianne C G Tjan-Heijnen, Frédéric Amant, Maartje C van Rij, Miel Theunis, Christine E M de Die-Smulders, Joris R Vermeesch, Merryn V E Macville
In this article, we defined comprehensive recommendations for the clinical follow-up of pregnant women with a malignancy-suspicious NIPT result, on the basis of the vast experience with population-based NIPT screening programs in two European countries complemented with published large data sets. These recommendations provide a tool for classifying NIPT results as malignancy-suspicious, and guide health care professionals in structured clinical decision making for the diagnostic process of pregnant women who receive such a malignancy-suspicious NIPT result...
April 12, 2024: JCO oncology practice
https://read.qxmd.com/read/38607688/carer-reported-sleep-disturbance-and-carer-and-teacher-rated-executive-functioning-in-children-with-prenatal-alcohol-exposure-and-fetal-alcohol-spectrum-disorder
#8
JOURNAL ARTICLE
Ned Chandler-Mather, Ali Crichton, Doug Shelton, Katrina Harris, Caroline Donovan, Sharon Dawe
Children with prenatal alcohol exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) have high rates of sleep disturbance and marked difficulties with executive functioning (EF). Sleep disturbance has been associated with poorer EF across development in typically developing children. The contribution of insomnia symptoms and nightmares to EF difficulties in children with PAE and FASD is unclear. The current study examined whether caregiver-reported insomnia symptoms and nightmares predicted difficulties with EF in children with PAE who were assessed at FASD diagnostic clinics...
April 12, 2024: Child Neuropsychology: a Journal on Normal and Abnormal Development in Childhood and Adolescence
https://read.qxmd.com/read/38604949/a-statistical-investigation-of-parameters-associated-with-low-cell-free-fetal-dna-fraction-in-maternal-plasma-for-noninvasive-prenatal-testing
#9
JOURNAL ARTICLE
Yun Pan, Xiaoli Pan, Danyan Zhuang, Ying Zhou, Jiangyang Xue, Shanshan Wu, Changshui Chen, Haibo Li
BACKGROUND: Noninvasive prenatal testing (NIPT) is the most common method for prenatal aneuploidy screening. Low fetal fraction (LFF) is the primary reason for NIPT failure. Consequently, factors associated with LFF should be elucidated for optimal clinical implementation of NIPT. METHODS: In this study, NIPT data from January 2019 to December 2022 from the laboratory records and obstetrical and neonatal data from the electronic medical records were collected and analyzed...
December 2024: Journal of Maternal-fetal & Neonatal Medicine
https://read.qxmd.com/read/38604316/characteristics-of-women-concordant-and-discordant-for-urine-drug-screens-for-cannabis-exposure-and-self-reported-cannabis-use-during-pregnancy
#10
JOURNAL ARTICLE
Ryan Bogdan, Shelby D Leverett, Anna M Constantino-Petit, Nicole Lashley-Simms, David B Liss, Emma C Johnson, Shannon N Lenze, Rachel E Lean, Tara A Smyser, Ebony B Carter, Christopher D Smyser, Cynthia E Rogers, Arpana Agrawal
BACKGROUND: Increasing cannabis use among pregnant people and equivocal evidence linking prenatal cannabis exposure to adverse outcomes in offspring highlights the need to understand its potential impact on pregnancy and child outcomes. Assessing cannabis use during pregnancy remains a major challenge with potential influences of stigma on self-report as well as detection limitations of easily collected biological matrices. OBJECTIVE: This descriptive study examined the concordance between self-reported (SR) cannabis use and urine drug screen (UDS) detection of cannabis exposure during the first trimester of pregnancy and characterized concordant and discordant groups for sociodemographic factors, modes of use, secondhand exposure to cannabis and tobacco, and alcohol use and cotinine positivity...
April 9, 2024: Neurotoxicology and Teratology
https://read.qxmd.com/read/38603981/prenatal-screening-after-preimplantation-genetic-testing-for-aneuploidy-time-to-evaluate-old-strategies
#11
JOURNAL ARTICLE
María Gabriela Palacios-Verdú, Alberto Rodríguez-Melcón, Ignacio Rodríguez, Annalisa Racca, Bernat Serra, Gerard Albaiges, Mónica Parriego, Pilar Prats
RESEARCH QUESTION: How does first-trimester aneuploidy screening perform in pregnancies achieved through IVF with preimplantation genetic testing for aneuploidy (PGT-A) in a medical setting? DESIGN: This retrospective cohort study was undertaken in a single tertiary care centre between January 2013 and June 2022. In total, 20,237 women had prenatal follow-up at the study centre and were included in the study. The women were divided into three groups: singleton pregnancies conceived through the transfer of a PGT-A-screened euploid embryo (n = 510); singleton pregnancies conceived through IVF without PGT-A (n = 3291); and singleton pregnancies conceived naturally (n = 16,436)...
December 4, 2023: Reproductive Biomedicine Online
https://read.qxmd.com/read/38594913/incorporation-of-vasa-previa-screening-into-a-routine-anomaly-scan-a-single-center-cohort-study
#12
JOURNAL ARTICLE
Millicent Nwandison, Elizabeth Daly-Jones, Alexandra Drought, Lisa Story, Philippe De-Rosnay, Neil Sebire, David Nyberg, Yinka Oyelese
INTRODUCTION: Vasa previa (VP), defined as unprotected fetal vessels traversing the membranes over the cervix, is associated with a high perinatal mortality when undiagnosed prenatally. Conversely, prenatal diagnosis with ultrasound and cesarean delivery before the membranes rupture is associated with excellent outcomes. However, controversy exists regarding screening for VP. In the UK, routine screening for VP is not recommended. The objective of this study was to report the incidence of VP and our experience in the detection of VP with a universal screening protocol at the time of the second-trimester fetal anomaly scan with third-trimester confirmation in an unselected population of pregnancies...
April 9, 2024: Acta Obstetricia et Gynecologica Scandinavica
https://read.qxmd.com/read/38593481/where-is-the-counseling-in-prenatal-genetic-counseling
#13
JOURNAL ARTICLE
Kendra L Schaa, Barbara B Biesecker
OBJECTIVE: Prenatal genetic testing is routinely offered to all pregnant patients in the United States and is variably offered to certain pregnant populations globally [1]. To achieve value-based, informed decision-making, we argue for a shift away from the predominant "teaching" model of genetic counseling practice that prioritizes information and counselor dominance, toward a "counseling" model of practice that prioritizes the patient's narrative, values and beliefs. DISCUSSION: Since prenatal testing began, genetic counseling has aimed to facilitate informed decision-making...
March 29, 2024: Patient Education and Counseling
https://read.qxmd.com/read/38590760/depression-in-pregnant-hispanic-women-risk-factors-pregnancy-outcomes-and-plasma-cytokines
#14
JOURNAL ARTICLE
Maureen E Groer, Kelley Baumgartel, Cary Springer, Tina Mutka, Teodor T Postolache
BACKGROUND: Maternal depression is considered a major contributor to morbidity and mortality in pregnancy. A population at risk are U.S. born or immigrant Hispanic women, and few prenatal depression or immune studies have focused on this population. OBJECTIVE: The research questions for the study were 1) What are the occurrences, risk factors and outcomes associated with depression in Hispanic pregnant women in the United States and 2) What are the associations of plasma immune cytokines and prenatal depression in this population...
July 2024: Brain, behavior, & immunity health
https://read.qxmd.com/read/38588252/the-clinical-value-of-optical-genome-mapping-in-the-rapid-characterization-of-rb1-duplication-and-15q23q24-2-triplication-for-more-appropriate-prenatal-genetic-counselling
#15
JOURNAL ARTICLE
Malek Bouassida, Denise Molina-Gomes, Fairouz Koraichi, Bérénice Hervé, Morgane Lhuilier, Clémence Duvillier, Jessica Le Gall, Marion Gauthier-Villars, Valérie Serazin, Thibaud Quibel, Rodolphe Dard, François Vialard
BACKGROUND: Despite recent advances in prenatal genetic diagnosis, medical geneticists still face considerable difficulty in interpreting the clinical outcome of copy-number-variant duplications and defining the mechanisms underlying the formation of certain chromosomal rearrangements. Optical genome mapping (OGM) is an emerging cytogenomic tool with proved ability to identify the full spectrum of cytogenetic aberrations. METHODS: Here, we report on the use of OGM in a prenatal diagnosis setting...
April 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38585728/risk-factors-for-food-insecurity-and-association-with-prenatal-care-utilization-among-women-who-took-opioids-during-pregnancy
#16
Lindsay M Parlberg, Jamie E Newman, Stephanie Merhar, Brenda Poindexter, Sara DeMauro, Scott Lorch, Myriam Peralta-Carcelen, Deanne Wilson-Costello, Namasivayam Ambalavanan, Catherine Limperopoulos, Nicole Mack, Jonathan M Davis, Michele Walsh, Carla M Bann
Background. Food insecurity during pregnancy is associated with poorer outcomes for both mothers and their newborns. Given the ongoing opioid crisis in the United States, mothers who take opioids during pregnancy may be at particular risk of experiencing food insecurity. Methods. This research utilized data from 254 biological mothers of infants in the Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW) Outcomes of Babies with Opioid Exposure (OBOE) Study. We examined factors associated with food insecurity among mothers of infants with antenatal opioid exposure and their unexposed (control) counterparts...
March 25, 2024: Research Square
https://read.qxmd.com/read/38585583/compound-heterozygous-b3galnt2-mutations-in-a-fetus-with-encephalocele-a-case-report
#17
Dandan Ling, Wanqin Xie, Xiao Mao, Shengzhi Yang, Haiyan Pang, Ping Yang, Ping Shen, Yabing Tang
An encephalocele is a congenital malformation characterized by protrusion of the intracranial contents through a cranial defect. We report that a fetus of a pregnant mother who had two consecutive pregnancies with ultrasound-detected encephalocele carried compound heterozygous variants in B3GALNT2 NM_152490.5:c.[1423C > T (p.Gln475Ter)]; [261-2A > G] of maternal and paternal origins, respectively, as confirmed by exome sequencing followed by Sanger sequencing validation. The present case implies that mutations in B3GALNT2 , a well-known dystroglycanopathy causative gene, may result in a phenotype of neural tube defect, providing new insights into the clinical spectrum of B3GALNT2 -related disorders...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38582887/prevention-of-alcohol-exposed-pregnancies-in-europe-the-far-seas-guidelines
#18
JOURNAL ARTICLE
Carla Bruguera, Lidia Segura-García, Katarzyna Okulicz-Kozaryn, Claudia Gandin, Silvia Matrai, Fleur Braddick, Marta Zin-Sędek, Luiza Slodownik, Emanuele Scafato, Joan Colom
INTRODUCTION: Drinking during pregnancy is the leading cause of birth defects and child developmental disorders in Europe. The adverse effects of drinking during pregnancy may include physical, behavioural and cognitive problems, known collectively as fetal alcohol spectrum disorders (FASD). Evidence-based comprehensive recommendations at the European level on how to implement preventive and treatment policies to reduce alcohol-exposed pregnancies are needed. FAR SEAS, a tendered service contract (number 20,187,106) awarded by the European Commission, aimed at developing guidelines to respond to this knowledge gap...
April 6, 2024: BMC Pregnancy and Childbirth
https://read.qxmd.com/read/38581475/screening-of-spinal-muscular-atrophy-carriers-and-prenatal-diagnosis-in-pregnant-women-in-yancheng-china
#19
JOURNAL ARTICLE
Huilin Sun, Jianli Zheng, Qing'e Zhang, Feifei Ying, Yadong Fu, Yongjuan Guan, Jing Wu, Yueyun Zhou, Jingjing Dong, Mengjun Xu, Fangfang Yang, Ning An, Ning Shi, Lu Zhang, Shu Zhu, Jianbing Liu, Min Li
Spinal muscular atrophy (SMA) is a neuromuscular disorder with an autosomal recessive inheritance pattern. Patients with severe symptoms may suffer respiratory failure, leading to death. The homozygous deletion of exon 7 in the SMN1 gene accounts for nearly 95% of all cases. Population carrier screening for SMA and prenatal diagnosis by amniocentesis for high-risk couples can assist in identifying the risk of fetal disease. We provided the SMA carrier screening process to 55,447 pregnant women in Yancheng from October 2020 to December 2022...
April 6, 2024: Biochemical Genetics
https://read.qxmd.com/read/38578615/prenatal-diagnosis-or-lack-thereof-of-arthrogryposis-multiplex-congenita-and-its-impact-on-the-perinatal-experience-of-parents-a-retrospective-survey
#20
JOURNAL ARTICLE
Sara Lemin, Harold J P van Bosse, Lauren Hutka, Shea Soberdash, Jay Patibandla
OBJECTIVE: To examine parental experiences during pregnancies affected by Arthrogryposis Multiplex Congenita (AMC) by identifying commonalities, risk factors, and areas for improvement in detection rates, care protocols, and patient experience. STUDY DESIGN: An online survey was distributed via AMC support groups on Facebook. Topics included demographics, risk factors, parental recall of sonographic findings, delivery characteristics and neonatal findings. Responses were divided into antenatally detected cases (ADCs) and postnatally detected cases (PDCs)...
April 5, 2024: Prenatal Diagnosis
keyword
keyword
5827
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.